1Laakso M, Kuusisto J. Understanding patient needs diabetology for cardiologists[J]. Eur Heart J,2003,5 (Suppl B):B5-B13.
2Rydesa L, Malmberg K. Who are the enemies? Diabetes mellitus---a major risk factor for ischaemic myocardial injury: new directions in the management of acute coronary syndromes in the diabetic patient[J].Eur Heart J,2002,4 (Suppl G): G21-G25.
3Gerstein HC. A disturbed glucose metabolic state(dysglycaemia) is a key risk factor for cardiovascular events[ J]. Eur Heart J, 2003,5 ( Suppl B) : B1-B4.
4Rubins HB, Robins SJ, Collins D, et al. For the veterans Affairs High Density Lipoprotein Cholesterol Intervention Trial Study Group. Gemfibrazil for the secondary prevention of coronary heart disease in men with low level of high-density lipoprotein cholesterol[ J ]. N Engl J Med,1999,341:410-418.
5Diabetes Atheroscleresis Intervention Study Investigators.Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes:the Diabetes Atherosclerosis Intervention Study,a randomized study[J]. Lancet,2001,357: 905-910.
6Malmberg K, Norhammar A, Wedel H, et al. Glycometabolic state at admission: important risk marker of mortallty in conventionally treated parents with diabetes mellitus and acute myocardial infarction:long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction(DIGAMI) Study [ J ]. Circulation, 1999, 99:2626-2632.
7Abizaid A, Cosra MA, Centemero M, et al. Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients:insights from the Arterial Revascularization Therapy Study(ARTS) trial[J]. Circulation,2001, 104:533-538.
